Show simple item record

dc.contributor.authorDevarajan, Priyadharshini
dc.contributor.authorJones, Michael C.
dc.contributor.authorKugler-Umana, Olivia
dc.contributor.authorVong, Allen M.
dc.contributor.authorXia, Jingya
dc.contributor.authorSwain, Susan L.
dc.date2022-08-11T08:09:49.000
dc.date.accessioned2022-08-23T16:45:01Z
dc.date.available2022-08-23T16:45:01Z
dc.date.issued2018-03-26
dc.date.submitted2018-05-30
dc.identifier.citation<p>Front Immunol. 2018 Mar 26;9:596. doi: 10.3389/fimmu.2018.00596. eCollection 2018. <a href="https://doi.org/10.3389/fimmu.2018.00596">Link to article on publisher's site</a></p>
dc.identifier.issn1664-3224 (Linking)
dc.identifier.doi10.3389/fimmu.2018.00596
dc.identifier.pmid29632538
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40611
dc.description.abstractAlthough much is known about the mechanisms by which pathogen recognition drives the initiation of T cell responses, including those to respiratory viruses, the role of pathogen recognition in fate decisions of T cells once they have become effectors remains poorly defined. Here, we review our recent studies that suggest that the generation of CD4 T cell memory is determined by recognition of virus at an effector "checkpoint." We propose this is also true of more highly differentiated tissue-restricted effector cells, including cytotoxic "ThCTL" in the site of infection and TFH in secondary lymphoid organs. We point out that ThCTL are key contributors to direct viral clearance and TFH to effective Ab response, suggesting that the most protective immunity to influenza, and by analogy to other respiratory viruses, requires prolonged exposure to antigen and to infection-associated signals. We point out that many vaccines used today do not provide such prolonged signals and suggest this contributes to their limited effectiveness. We also discuss how aging impacts effective CD4 T cell responses and how new insights about the response of aged naive CD4 T cells and B cells might hold implications for effective vaccine design for both the young and aged against respiratory viruses.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=29632538&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright: © 2018 Devarajan, Jones, Kugler-Umana, Vong, Xia and Swain. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCD4 T cells
dc.subjectTFH
dc.subjectThCTL
dc.subjectimmune memory
dc.subjectinfluenza
dc.subjectpathogen recognition
dc.subjectvirus
dc.subjectImmunology of Infectious Disease
dc.subjectImmunopathology
dc.subjectMicrobiology
dc.subjectPathology
dc.subjectRespiratory Tract Diseases
dc.subjectVirus Diseases
dc.subjectViruses
dc.titlePathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus
dc.typeJournal Article
dc.source.journaltitleFrontiers in immunology
dc.source.volume9
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4426&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3415
dc.identifier.contextkey12222303
refterms.dateFOA2022-08-23T16:45:01Z
html.description.abstract<p>Although much is known about the mechanisms by which pathogen recognition drives the initiation of T cell responses, including those to respiratory viruses, the role of pathogen recognition in fate decisions of T cells once they have become effectors remains poorly defined. Here, we review our recent studies that suggest that the generation of CD4 T cell memory is determined by recognition of virus at an effector "checkpoint." We propose this is also true of more highly differentiated tissue-restricted effector cells, including cytotoxic "ThCTL" in the site of infection and TFH in secondary lymphoid organs. We point out that ThCTL are key contributors to direct viral clearance and TFH to effective Ab response, suggesting that the most protective immunity to influenza, and by analogy to other respiratory viruses, requires prolonged exposure to antigen and to infection-associated signals. We point out that many vaccines used today do not provide such prolonged signals and suggest this contributes to their limited effectiveness. We also discuss how aging impacts effective CD4 T cell responses and how new insights about the response of aged naive CD4 T cells and B cells might hold implications for effective vaccine design for both the young and aged against respiratory viruses.</p>
dc.identifier.submissionpathoapubs/3415
dc.contributor.departmentDepartment of Pathology
dc.source.pages596


Files in this item

Thumbnail
Name:
fimmu_09_00596.pdf
Size:
428.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright: © 2018 Devarajan, Jones, Kugler-Umana, Vong, Xia and Swain. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Except where otherwise noted, this item's license is described as Copyright: © 2018 Devarajan, Jones, Kugler-Umana, Vong, Xia and Swain. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.